NeOnc Technologies Holdings is trading 10.42% down at $2.96 as biotechnology shares weaken.
- The XBI ETF was down 2.11% on September 16, 2026.
- The broader risk-off move followed the Federal Reserveβs 25-basis-point rate hike and hawkish outlook, pressuring growth-sensitive equities.
- No clear negative company-specific announcement was identified on September 16; recent news was positive, including insider purchases and earlier clinical-development updates. Sector and macro pressure appear primary.